Article Text

Download PDFPDF
News in brief

Statistics from

Equine grass sickness vaccine trial

The Animal Health Trust (AHT) is appealing to vets to encourage clients who keep horses on premises that have been affected by at least one case of equine grass sickness (EGS) in the past three years to sign up to the second year of its EGS vaccine trial. The trial involves enrolled horses or ponies receiving either a course of Clostridium botulinum type C toxoid vaccine or an inactive placebo, as well as an annual booster. The incidence of EGS is monitored throughout the trial to determine the efficacy of the vaccine, and enrolled animals are closely monitored for the duration of the trial. …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.